+ intestinal stem cells are required for organoid survival after genotoxic injury

Joseph Lee,Antoine Gleizes,Felipe Takaesu,Sarah F Webster,Taylor Hailstock,Nick Barker,Adam D Gracz
DOI: https://doi.org/10.1101/2024.04.08.588400
2024-04-25
Abstract:Progenitors and mature cells can maintain the intestinal epithelium by dedifferentiation and facultative intestinal stem cell (fISC) function when active ISCs (aISCs) are lost to damage. Here, we sought to model fISC activation in intestinal organoids with doxorubicin (DXR), a chemotherapeutic known to ablate + aISCs . We identified low and high doses of DXR compatible with long-term organoid survival. Similar fISC gene activation was observed between organoids treated with low vs high DXR, despite significantly decreased survival at the higher dose. aISCs exhibit dose-dependent loss after DXR but survive at doses compatible with organoid survival. We ablated residual aISCs after DXR using a allele and observed that aISC survival of the initial genotoxic insult is required for organoid survival following DXR. These results suggest that while typical fISC genes are activated by DXR injury in organoids, functional stemness remains dependent on the aISC pool. Our data establish a reproducible model of DXR injury in intestinal organoids and reveal differences in responses to an established damage modality.
Cell Biology
What problem does this paper attempt to address?